Fuzeon Case Study: Needle-Free Version Offers Potential to Extend Life of Antiretroviral, Fuzeon
Marketline
Resource access
Open the content from the main option or choose another available source.
Institutional access available
How to cite
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
Marketline (s. f.). Fuzeon Case Study: Needle-Free Version Offers Potential to Extend Life of Antiretroviral, Fuzeon. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=5DBQ&scope=site
MLA
Marketline. Fuzeon Case Study: Needle-Free Version Offers Potential to Extend Life of Antiretroviral, Fuzeon. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=5DBQ&scope=site.
Chicago
Marketline. s. f. Fuzeon Case Study: Needle-Free Version Offers Potential to Extend Life of Antiretroviral, Fuzeon. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=5DBQ&scope=site.
Harvard
Marketline s. f, Fuzeon Case Study: Needle-Free Version Offers Potential to Extend Life of Antiretroviral, Fuzeon, Marketline, available at: https://search.ebscohost.com/direct.asp?db=bth&jid=5DBQ&scope=site [Accessed 7 Aug. 2026].
Resource details
Bibliographic information to help confirm that this is the correct material.
- Title
- Fuzeon Case Study: Needle-Free Version Offers Potential to Extend Life of Antiretroviral, Fuzeon
- Author / contributors
- Marketline
- Publisher
- Marketline